Entry Detail



General Information

Database ID:exR0080611
RNA Name:RPL4
RNA Type:mRNA
Chromosome:chr15
Starnd:-
Coordinate:
Start Site(bp):66498015End Site(bp):66524532
External Links:ENSG00000174444



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AIF1L
chr9
131096476
131123152
+
ADD1
chr4
2843857
2930076
+
AL049629.2
chr11
33698261
33722467
-
AL133352.1
chr10
100505628
100529881
-
AASDHPPT
chr11
106075501
106098699
+
AC004223.3
chr17
35011349
35121493
-
ABT1
chr6
26596953
26600739
+
ADSL
chr22
40346500
40390463
+
AC245033.1
chr15
82536788
82573194
-
AC013394.1
chr15
92883413
92949230
+
AC008982.1
chr19
38817471
38840178
-
AC003002.3
chr19
57389884
57419994
+
ACTN4
chr19
38647649
38731589
+
ADD2
chr2
70607618
70768225
-
ADGRL2
chr1
81306160
81992436
+
AC004922.1
chr7
99325879
99394653
+
AC120057.2
chr17
7240427
7244635
-
ALAD
chr9
113386312
113401290
-
ACTC1
chr15
34790230
34795549
-
ADAR
chr1
154582057
154628013
-
AIMP1
chr4
106315544
106349456
+
ADCY3
chr2
24819169
24919839
-
AC015813.2
chr17
57989038
58007246
-
ABRACL
chr6
139028745
139043302
+
AD000671.2
chr19
35739252
35745432
-
ACP5
chr19
11574660
11579008
-
AGBL5
chr2
27042364
27070622
+
ABCC4
chr13
95019835
95301475
-
AC007192.1
chr19
18153158
18178117
+
AGAP2
chr12
57723761
57742157
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-4745-5p
chr19
804941
804963
+
hsa-miR-6889-5p
chr22
41253023
41253045
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005899.4
chr17
32328441
32329395
+
AC007952.4
chr17
19112000
19112636
-
AC016026.1
chr22
17787652
17811497
-
AC016876.2
chr17
7581964
7584086
-
AC026362.1
chr12
122975320
122982907
+
AC051619.7
chr15
45200325
45200632
-
AC126365.1
chr17
20788071
20789584
+
AC245033.4
chr15
82533175
82540008
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL117378.1
chr6
131901963
131920565
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA